Two Sigma Investments’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $556K | Buy |
114,117
+12,875
| +13% | +$72K | ﹤0.01% | 3674 |
|
|
2025
Q4 | $677K | Buy |
101,242
+53,826
| +114% | +$319K | ﹤0.01% | 3157 |
|
|
2025
Q3 | $208K | Buy |
47,416
+27,637
| +140% | +$131K | ﹤0.01% | 3365 |
|
|
2025
Q2 | $87.8K | Buy |
19,779
+2,446
| +14% | +$10.2K | ﹤0.01% | 3011 |
|
|
2025
Q1 | $98.1K | Buy |
17,333
+13,751
| +384% | +$176K | ﹤0.01% | 2967 |
|
|
2024
Q4 | $75.6K | Buy |
3,582
+211
| +6% | +$4.85K | ﹤0.01% | 3001 |
|
|
2024
Q3 | $90.7K | Sell |
3,371
-2,551
| -43% | -$75.1K | ﹤0.01% | 2910 |
|
|
2024
Q2 | $169K | Buy |
5,922
+1,724
| +41% | +$60.5K | ﹤0.01% | 2763 |
|
|
2024
Q1 | $178K | Sell |
4,198
-1,126
| -21% | -$50.6K | ﹤0.01% | 2742 |
|
|
2023
Q4 | $285K | Sell |
5,324
-7,778
| -59% | -$351K | ﹤0.01% | 2713 |
|
|
2023
Q3 | $563K | Buy |
13,102
+1,090
| +9% | +$50.3K | ﹤0.01% | 2225 |
|
|
2023
Q2 | $659K | Buy |
12,012
+5,153
| +75% | +$283K | ﹤0.01% | 2191 |
|
|
2023
Q1 | $288K | Sell |
6,859
-6,125
| -47% | -$182K | ﹤0.01% | 2437 |
|
|
2022
Q4 | $360K | Sell |
12,984
-4,328
| -25% | -$107K | ﹤0.01% | 2170 |
|
|
2022
Q3 | $443K | Buy |
17,312
+7,360
| +74% | +$243K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $358K | Buy |
9,952
+4,683
| +89% | +$211K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $327K | Sell |
5,269
-8,437
| -62% | -$499K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $966K | Sell |
13,706
-7,908
| -37% | -$562K | ﹤0.01% | 2589 |
|
|
2021
Q3 | $1.51M | Sell |
21,614
-4,394
| -17% | -$350K | ﹤0.01% | 2238 |
|
|
2021
Q2 | $2.17M | Buy |
26,008
+12,116
| +87% | +$857K | 0.01% | 1796 |
|
|
2021
Q1 | $758K | Buy |
13,892
+3,894
| +39% | +$189K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $429K | Buy |
9,998
+4,497
| +82% | +$168K | ﹤0.01% | 2618 |
|
|
2020
Q3 | $166K | Buy |
5,501
+410
| +8% | +$13.8K | ﹤0.01% | 2860 |
|
|
2020
Q2 | $158K | Sell |
5,091
-1,921
| -27% | -$51.8K | ﹤0.01% | 2702 |
|
|
2020
Q1 | $155K | Sell |
7,012
-10,099
| -59% | -$274K | ﹤0.01% | 2737 |
|
|
2019
Q4 | $522K | Sell |
17,111
-9,698
| -36% | -$279K | ﹤0.01% | 2766 |
|
|
2019
Q3 | $824K | Buy |
26,809
+2,914
| +12% | +$72.4K | ﹤0.01% | 2145 |
|
|
2019
Q2 | $478K | Buy |
23,895
+18,920
| +380% | +$554K | ﹤0.01% | 2529 |
|
|
2019
Q1 | $214K | Sell |
4,975
-3,355
| -40% | -$122K | ﹤0.01% | 2784 |
|
|
2018
Q4 | $265K | Sell |
8,330
-4,923
| -37% | -$194K | ﹤0.01% | 2546 |
|
|
2018
Q3 | $696K | Buy |
+13,253
| New | +$744K | ﹤0.01% | 2237 |
|
|
2017
Q3 | – | Sell |
-1,040
| Closed | -$27K | – | 2967 |
|
|
2017
Q2 | $27K | Sell |
1,040
-30
| -3% | -$742 | ﹤0.01% | 2896 |
|
|
2017
Q1 | $28K | Sell |
1,070
-10
| -0.9% | -$288 | ﹤0.01% | 2825 |
|
|
2016
Q4 | $33K | Sell |
1,080
-10
| -0.9% | -$254 | ﹤0.01% | 3014 |
|
|
2016
Q3 | $30K | Sell |
1,090
-10
| -0.9% | -$278 | ﹤0.01% | 3044 |
|
|
2016
Q2 | $31K | Sell |
1,100
-140
| -11% | -$4.45K | ﹤0.01% | 2854 |
|
|
2016
Q1 | $37K | Sell |
1,240
-3,442
| -74% | -$97.6K | ﹤0.01% | 2728 |
|
|
2015
Q4 | $162K | Buy |
4,682
+3,675
| +365% | +$126K | ﹤0.01% | 2508 |
|
|
2015
Q3 | $38K | Sell |
1,007
-867
| -46% | -$40.3K | ﹤0.01% | 2101 |
|
|
2015
Q2 | $107K | Sell |
1,874
-780
| -29% | -$44.4K | ﹤0.01% | 2708 |
|
|
2015
Q1 | $154K | Hold |
2,654
| – | – | ﹤0.01% | 2520 |
|
|
2014
Q4 | $150K | Sell |
2,654
-1,066
| -29% | -$50.8K | ﹤0.01% | 2094 |
|
|
2014
Q3 | $152K | Sell |
3,720
-3,400
| -48% | -$156K | ﹤0.01% | 1640 |
|
|
2014
Q2 | $324K | Buy |
7,120
+4,775
| +204% | +$201K | ﹤0.01% | 1799 |
|
|
2014
Q1 | $111K | Buy |
+2,345
| New | +$107K | ﹤0.01% | 1875 |
|
|
2013
Q4 | – | Sell |
-2,018
| Closed | -$80K | – | 2254 |
|
|
2013
Q3 | $80K | Sell |
2,018
-38
| -2% | -$1.49K | ﹤0.01% | 1765 |
|
|
2013
Q2 | $74K | Buy |
+2,056
| New | +$78.7K | ﹤0.01% | 1904 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
